The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Pilot trial of an indoleamine 2,3-dioxygenase-1 (IDO1) inhibitor plus a multipeptide melanoma vaccine in patients with advanced melanoma.
 
Craig L. Slingluff
Consulting or Advisory Role - Immatics (Inst); Polynoma (Inst)
Research Funding - 3M (Inst); GlaxoSmithKline (Inst); Merck Sharp & Dohme (Inst); Theraclion (Inst)
Patents, Royalties, Other Intellectual Property - Licensing and Ventures Group of the University of Virginia
 
Steven Fling
Travel, Accommodations, Expenses - Cambridge Healthtech Institute; NantHealth
 
Ileana S Mauldin
No Relationships to Disclose
 
Marc S. Ernstoff
Stock and Other Ownership Interests - GE Healthcare
Consulting or Advisory Role - Bristol-Myers Squibb; Celyad; EMD Serono; Lion Biotechnologies; Omniseq
Research Funding - Alkermes (Inst); Bristol-Myers Squibb (Inst); Merck (Inst); Merrimack (Inst)
 
Brent Allen Hanks
Honoraria - Novartis; Virginia Oncology Associates
Consulting or Advisory Role - EMD Serono; G1 Therapeutics
Speakers' Bureau - CE Concepts
Research Funding - AstraZeneca; GlaxoSmithKline; Merck; OncoMed
Patents, Royalties, Other Intellectual Property - Inhibiting paracrine Wnt ligand signaling to augment checkpoint inhibitor immunotherapy. (Inst); Modulating the metabolism of dendritic cells to enhance anti-tumor immunity. (Inst)
 
Keith A. Delman
No Relationships to Disclose
 
David H. Lawson
No Relationships to Disclose
 
Brian Gastman
Consulting or Advisory Role - Castle Biosciences; Quest Imaging
Speakers' Bureau - Castle Biosciences; Merck
Research Funding - Abbvie (Inst); Alkermes (Inst); Celldex (Inst); Merck (Inst)
 
Judith C Kaiser
No Relationships to Disclose
 
Martin A. Cheever
No Relationships to Disclose